Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Contract Win

20 Nov 2008 07:00

RNS Number : 5213I
e2v technologies PLC
20 November 2008
 



20 November  2008 

e2v technologies plc

Contract Win 

e2v technologies, a specialist developer and manufacturer of high technology components and sub-systems, announces an £11m contract renewal to supply Varian Medical Systems, Inc., headquartered in Palo Alto, US, with electron devices for incorporation into linear accelerators, for use in radiotherapy cancer treatment and cargo screening systems.

The contract will be worth at least £11m (payments will be in US dollars at the prevailing exchange rate) over two years, and is the first of a number of anticipated multi-year contract renewals for electron devices used in linear accelerators. e2v's products generate and deliver the microwave power required from the linear accelerator to produce X-rays used in both the imaging and radiation treatment of tumours as well as the imaging systems within cargo screening equipment.

This contract represents an increase in business with this customer, has the potential to increase in value over the term of the agreement, and is in line with management's growth expectations for this sector.

Keith Attwood, Chief Executive of e2v said: ``This multi-year contract renewal with Varian is a demonstration of the strong and close relationships we build with our strategic partners.''

For further information:

e2v technologies plc

Tel: +44 (0)1245 493493

Keith Attwood/Mike Hannant

www.e2v.com

Financial Dynamics

Tel: +44 (0)20 7269 7225

Jon Simmons/Sophie Kernon

   

NOTES FOR EDITORS

e2v 

e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical and science, aerospace and defence, and commercial and industrial markets.

e2v has 4 major product groups:

High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, and radar systems

Advanced Imaging sensors and cameras for applications including industrial process control, dental X-ray systems, space science and life sciences

Specialist semiconductors, including logic, memory and microprocessors for high reliability mission-critical programs in avionics, defence and telecommunications, sensor data acquisition, and high speed data conversion

A range of professional sensing products for applications including fire, rescue and security thermal imaging, X-ray spectroscopy, and military surveillance, targeting and guidance

For the year ended 31 March 2008, e2v achieved sales of £205m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base. 

The Company is headquartered in the United Kingdom and has approximately 1800 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.

Further information is available from www.e2v.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFKCKDABDDFDD
Date   Source Headline
11th Dec 20083:04 pmRNSNotification of Major Interests In Shares
1st Dec 20084:39 pmRNSDirector/PDMR Shareholding
1st Dec 20084:36 pmRNSNotification of Major Interests in Shares
28th Nov 200811:25 amRNSDirector/PDMR Shareholding
26th Nov 20085:21 pmRNSDirector/PDMR Shareholding
24th Nov 20087:00 amRNSInterim Results
20th Nov 20087:00 amRNSContract Win
13th Oct 20089:19 amRNSCompletion of Acquisition
10th Oct 20087:00 amRNSPeriod-end Update
3rd Oct 200811:18 amRNSTotal Voting Rights
3rd Oct 200811:17 amRNSNotification Of Major Interests In Shares
19th Sep 20084:52 pmRNSSecond Price Monitoring Extn
19th Sep 20084:35 pmRNSPrice Monitoring Extension
18th Sep 200812:13 pmRNSResult of EGM
4th Sep 20085:28 pmRNSLong Term Incentive Plan
2nd Sep 20083:38 pmRNSPosting of circular
1st Sep 20087:00 amRNSProposed acquisition
29th Jul 20089:12 amRNSAdditional Listing
25th Jul 20084:21 pmRNSResult of AGM
25th Jul 20087:00 amRNSInterim Management Statement
24th Jul 20081:48 pmRNSNotification of Major Interes
17th Jul 20089:19 amRNSLong Term Incentive Plan
14th Jul 20089:27 amRNSNotification of Major Interes
7th Jul 20084:44 pmRNSTotal Voting Rights
7th Jul 20083:53 pmRNSNotification of Major Interes
20th Jun 200811:41 amRNSAnnual Report and Accounts
13th Jun 200812:04 pmRNSNotice of Interests in Shares
2nd Jun 20087:00 amRNSFinal Results
23rd May 20083:14 pmRNSNotice of Interests in Shares
15th May 20081:55 pmRNSNotice of Interests in Shares
15th May 20089:32 amRNSNotice of Interest in Shares
9th May 20087:00 amRNSNotice of Results
29th Apr 20089:30 amRNSNotice of Interests in Shares
28th Apr 20089:16 amRNSNotice of Interests in Shares
22nd Apr 20087:00 amRNSContract Win
18th Apr 200810:10 amRNSNotice of Interest in Shares
10th Apr 20087:00 amRNS2008 Year End Trading Update
5th Mar 200811:33 amRNSNotice of Interest in Shares
29th Feb 200812:45 pmRNSNotice of Interest in Shares
28th Feb 20089:13 amRNSTotal Voting Rights
27th Feb 200811:38 amRNSNotice of Interest in Shares
27th Feb 200811:32 amRNSNotice of Interest in Shares
20th Feb 20084:32 pmRNSNotice of Interest in Shares
15th Feb 20087:00 amRNSInterim Management Statement
11th Feb 20087:00 amRNSe2v secures US DoD contract
17th Jan 20087:00 amRNSAnalyst & Investor Site Visit
11th Jan 200811:39 amRNSAdditional Listing
17th Dec 20079:14 amRNSTotal Voting Rights
14th Dec 20071:41 pmRNSDirector/PDMR Shareholding
4th Dec 20074:33 pmRNSInterest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.